Literature DB >> 12855825

Operational definitions for the NINDS-AIREN criteria for vascular dementia: an interobserver study.

Elisabeth C W van Straaten1, Philip Scheltens, Dirk L Knol, Mark A van Buchem, Ewout J van Dijk, Paul A M Hofman, Giorgos Karas, Olafur Kjartansson, Frank-Erik de Leeuw, Niels D Prins, Reinhold Schmidt, Marieke C Visser, Henry C Weinstein, Frederik Barkhof.   

Abstract

BACKGROUND AND
PURPOSE: Vascular dementia (VaD) is thought to be the most common cause of dementia after Alzheimer's disease. The commonly used International Workshop of the National Institute of Neurological Disorders and Stroke (NINDS) and the Association Internationale pour la Recherche et l'Enseignement en Neurosciences (AIREN) criteria for VaD necessitate evidence of vascular disease on CT or MRI of the brain. The purposes of our study were to operationalize the radiological part of the NINDS-AIREN criteria and to assess the effect of this operationalization on interobserver agreement.
METHODS: Six experienced and 4 inexperienced observers rated a set of 40 MRI studies of patients with clinically suspected VaD twice using the NINDS-AIREN set of radiological criteria. After the first reading session, operational definitions were conceived, which were subsequently used in the second reading session. Interobserver reproducibility was measured by Cohen's kappa.
RESULTS: Overall agreement at the first reading session was poor (kappa=0.29) and improved slightly after application of the additional definitions (kappa=0.38). Raters in the experienced group improved their agreement from almost moderate (kappa=0.39) to good (0.62). The inexperienced group started out with poor agreement (kappa=0.17) and did not improve (kappa=0.18). The experienced group improved in both the large- and small-vessel categories, whereas the inexperienced group improved generally in the extensive white matter hyperintensities categories.
CONCLUSIONS: Considerable interobserver variability exists for the assessment of the radiological part of the NINDS-AIREN criteria. Use of operational definitions improves agreement but only for already experienced observers.

Entities:  

Mesh:

Year:  2003        PMID: 12855825     DOI: 10.1161/01.STR.0000083050.44441.10

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  33 in total

1.  Diagnosis, risk factors, and treatment of vascular dementia.

Authors:  Oscar L Lopez; Lewis H Kuller; James T Becker
Journal:  Curr Neurol Neurosci Rep       Date:  2004-09       Impact factor: 5.081

2.  Toward a pathological definition of vascular dementia.

Authors:  Lea Tenenholz Grinberg; Helmut Heinsen
Journal:  J Neurol Sci       Date:  2010-12-15       Impact factor: 3.181

Review 3.  Neuroradiological findings in vascular dementia.

Authors:  Ali Guermazi; Yves Miaux; Alex Rovira-Cañellas; Joyce Suhy; Jon Pauls; Ria Lopez; Holly Posner
Journal:  Neuroradiology       Date:  2006-11-18       Impact factor: 2.804

Review 4.  Use of laboratory and imaging investigations in dementia.

Authors:  W M van der Flier; P Scheltens
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-12       Impact factor: 10.154

5.  Dementia and movement disorders.

Authors:  D Dormont; D J Seidenwurm
Journal:  AJNR Am J Neuroradiol       Date:  2008-01       Impact factor: 3.825

Review 6.  Other dementias.

Authors:  Gaida Krumina
Journal:  Neuroradiology       Date:  2011-09       Impact factor: 2.804

7.  [Prevention of vascular dementia. Evidence and practice].

Authors:  S Lüders; S Stöve; J Schrader
Journal:  Internist (Berl)       Date:  2012-02       Impact factor: 0.743

8.  Evaluation of treatment effects in Alzheimer's and other neurodegenerative diseases by MRI and MRS.

Authors:  S G Mueller; N Schuff; M W Weiner
Journal:  NMR Biomed       Date:  2006-10       Impact factor: 4.044

9.  Small vessel versus large vessel vascular dementia: risk factors and MRI findings.

Authors:  S S Staekenborg; E C W van Straaten; W M van der Flier; R Lane; F Barkhof; P Scheltens
Journal:  J Neurol       Date:  2008-07-18       Impact factor: 4.849

10.  Accelerating regional atrophy rates in the progression from normal aging to Alzheimer's disease.

Authors:  Jasper D Sluimer; Wiesje M van der Flier; Giorgos B Karas; Ronald van Schijndel; Josephine Barnes; Richard G Boyes; Keith S Cover; Sílvia D Olabarriaga; Nick C Fox; Philip Scheltens; Hugo Vrenken; Frederik Barkhof
Journal:  Eur Radiol       Date:  2009-07-18       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.